Jump to content

Methylenedioxyhydroxyethylamphetamine

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Graeme Bartlett (talk | contribs) at 08:52, 27 August 2019 (pubchem). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Methylenedioxyhydroxyethylamphetamine
Names
IUPAC name
2-(2-Benzo[1,3]dioxol-5-yl-1-methylethylamino)ethanol
Other names
3,4-Methylenedioxy-N-hydroxyethylamphetamine
3,4-Methylenedioxy-1-(alpha-methylaminohydroxyethyl)ethane
MDOHET, MDHET, MDHEA
Identifiers
3D model (JSmol)
ChemSpider
  • InChI=1S/C12H17NO3/c1-9(13-4-5-14)6-10-2-3-11-12(7-10)16-8-15-11/h2-3,7,9,13-14H,4-6,8H2,1H3 ☒N
    Key: SCUUYKMQDUDNBP-UHFFFAOYSA-N ☒N
  • C1=C2C(=CC=C1CC(C)NCCO)OCO2
Properties
C12H17NO3
Molar mass 223.271 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)

MDHOET, or 3,4-methylenedioxy-N-hydroxyethylamphetamine, is a lesser-known psychedelic drug and a substituted amphetamine. It is also the N-hydroxyethyl analogue of MDA. MDHOET was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 50 mg. MDHOET produces few to no effects. Very little data exists about the pharmacology, pharmacokinetics, effects, and toxicity of MDHOET.

Legality

United Kingdom

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[1]

See also

References

  1. ^ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Retrieved 12 March 2014.

External links

Template:PiHKAL